Compound Information
Structure
Product Name
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-
yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-
4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3)
CAS No.
202189-77-3
| Property | Details |
|---|---|
| Product Name | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2- yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)- 4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3) |
| Structure |  |
| CAS No. | CAS No. 202189-77-3 |
| Related to Pharma | Bilastine |
| Molecular Formula | C32H44N4O2 |
| Formula Weight | 516.72 |
| Storage Condition | Ambient |
Compound Specification
| Property | Details |
|---|---|
| Description | Light brown to Off white color powder |
| Identification by HPLC | The retention time of principal peak in the sample chromatogram should match with that of working standard chromatogram in the test, Related substance by HPLC |
| Chromatographic purity by HPLC | |
| Purity | Not less than 99.00% |
SDS Information
Product Identification
Chemical Name : 2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2- yl)piperidin-1-
yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl- 4,5-dihydrooxazole
CAS No : 202189-77-3
Molecular Weight : 516.7
Chemical Formula : C32H44N4O2
Composition/Information on Ingredients
| Ingredient | CAS No | Classification | Hazardous |
|---|---|---|---|
| 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2- yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)- 4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3) | 202189-77-3 | — | Nil |
Hazards Identification
Emergency Overview
Appearance : White Hygroscopic Solid
Potential Health Effects
Eye : No information found.
Skin : No information found.
Ingestion: No information found.
Inhalation: No information found.
Chronic: No information found.
First Aid Measures Eyes
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes.
Get medical aid.
Skin: In case of contact, flush skin with plenty of water.
Ingestion: Medical assistance for gastric lavage.
Inhalation: Remove to fresh air, artificial respiration or oxygen if necessary.
Notes to Physician: Bilastine Impurity C can be washed with plenty of water in case of any exposure
Fire Fighting Measures
Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam.
Accidental Release Measures
Personal Precautions : Wear self-contained breathing apparatus, avoid dust formation.
Spills/Leaks: Wash with plenty of water, provide adequate ventilation.
Handling and Storage
Handling: Wear surgical gloves
Storage: No information found.
Exposure Controls/Personal Protection
Eyes: Wear appropriate protective eyeglasses or chemical safety goggles.
Skin : Wear appropriate protective Full sleeves apron
Clothing: Cotton
Respirators: Self-contained breathing apparatus
Physical and Chemical Properties
Appearance : White Hygroscopic Solid
Odor : Odorless
MeltingPoint : NA
pH : Basic
Vapor pressure : NA
Vepor Density : NA
Evaportion Rate : NA
Viscosity : NA
BoilingPoint : NA
DecompositionTemp : NA
AutoignitionTemp. : NA
FlashPoint : NA
NFPARating : NA
Explosion Limits
Lower : NA
Upper : NA
Solubility : Chloroform, Methanol
Specific Gravity/Density : NA
Stability and Reactivity
Chemical Stability: NA
Conditions to Avoid: Direct contract to skin
Hazardous Decomposition Products: NIL
Hazardous Polymerization: NIL
Toxicological Information
Not available.
Ecological Information
Not available.
Disposal Considerations
RCRAP-Series : Can be incinerated
Transport Information
Not available.
Regulatory Information
TSCA : Attached the letter
Health & Safety Reporting List : No data Available
Chemical test Results : Chemical analysis report is attached.
Other Information
The information above is believed to be accurate and represents the best information currently
available to us.